These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 38353222)
21. Immune-mediated necrotizing myopathy: A comprehensive review of the pathogenesis, clinical features, and treatments. Li C; Liu H; Yang L; Liu R; Yin G; Xie Q J Autoimmun; 2024 Sep; 148():103286. PubMed ID: 39033686 [TBL] [Abstract][Full Text] [Related]
22. Immune-mediated necrotizing myopathy: Unusual presentations of a treatable disease. Nicolau S; Milone M; Tracy JA; Mills JR; Triplett JD; Liewluck T Muscle Nerve; 2021 Dec; 64(6):734-739. PubMed ID: 34617293 [TBL] [Abstract][Full Text] [Related]
26. Influenza A (H3N2) infection followed by anti-signal recognition particle antibody-positive necrotizing myopathy: A case report. Iriki J; Yamamoto K; Senju H; Nagaoka A; Yoshida M; Iwasaki K; Ashizawa N; Hirayama T; Tashiro M; Takazono T; Imamura Y; Miyazaki T; Izumikawa K; Yanagihara K; Tsujino A; Fukuoka J; Uetani M; Satoh M; Mukae H Int J Infect Dis; 2021 Feb; 103():33-36. PubMed ID: 33217572 [TBL] [Abstract][Full Text] [Related]
27. [A case of anti-SRP antibody-positive immune-mediated necrotizing myopathy triggered by human parvovirus B19 infection]. Suzuki I; Nakao R; Unai Y; Miyazaki Y Rinsho Shinkeigaku; 2022 May; 62(5):363-368. PubMed ID: 35474284 [TBL] [Abstract][Full Text] [Related]
28. Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy. Lia A; Annese T; Fornaro M; Giannini M; D'Abbicco D; Errede M; Lorusso L; Amati A; Tampoia M; Trojano M; Virgintino D; Ribatti D; Serlenga L; Iannone F; Girolamo F Rheumatology (Oxford); 2022 Aug; 61(8):3448-3460. PubMed ID: 34864921 [TBL] [Abstract][Full Text] [Related]
29. Immune-mediated necrotizing myopathy with concomitant development of Kikuchi-Fujimoto disease. Ichikawa T; Furukawa R; Shimojima Y; Hoshino Y; Kishida D; Sekijima Y Int J Rheum Dis; 2024 Jan; 27(1):e14894. PubMed ID: 37653623 [TBL] [Abstract][Full Text] [Related]
30. Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series. Xiong A; Yang G; Song Z; Xiong C; Liu D; Shuai Y; He L; Zhang L; Guo Z; Shuai S Ther Adv Neurol Disord; 2021; 14():1756286421998918. PubMed ID: 33786066 [TBL] [Abstract][Full Text] [Related]
31. Paraneoplastic Anti-3-hydroxy-3-methylglutary-coenzyme A Reductase Antibody-positive Immune-mediated Necrotizing Myopathy in a Patient with Uterine Cancer. Mizuma A; Kouchi M; Netsu S; Yutani S; Kitao R; Suzuki S; Murata K; Nagata E; Takizawa S Intern Med; 2017; 56(14):1915-1918. PubMed ID: 28717093 [TBL] [Abstract][Full Text] [Related]
32. Immune-Mediated Necrotizing Myopathy Initially Presenting as Erythema Nodosum. Ying S; Li S; Tang S; Sun Q; Fang D; Li Y; Zhu D; Fang H; Qiao J J Inflamm Res; 2020; 13():471-476. PubMed ID: 32922062 [TBL] [Abstract][Full Text] [Related]
33. Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study. Picard C; Vincent T; Lega JC; Hue S; Fortenfant F; Lakomy D; Humbel RL; Goetz J; Molinari N; Bardin N; Bertin D; Johanet C; Chretien P; Dubucquoi S; Streichenberger N; Desplat-Jégo S; Bossuyt X; Sibilia J; Abreu I; Chevailler A; Fabien N Immunol Res; 2016 Jun; 64(3):677-86. PubMed ID: 26744256 [TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics of myositis patients with isolated anti-U1 ribonucleoprotein antibody resemble immune-mediated necrotizing myopathy. Ge Y; Yang H; Jiang W; Tian X; Lu X; Wang G Ther Adv Musculoskelet Dis; 2023; 15():1759720X231181336. PubMed ID: 37465567 [TBL] [Abstract][Full Text] [Related]
35. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697 [TBL] [Abstract][Full Text] [Related]
36. [Clinical and pathological characteristics of immune mediated necrotizing myopathy]. Yang HX; Tian XL; Jiang W; Li WL; Liu QY; Peng QL; Wang GC; Lu X Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):989-995. PubMed ID: 31848492 [TBL] [Abstract][Full Text] [Related]
37. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series. Valiyil R; Casciola-Rosen L; Hong G; Mammen A; Christopher-Stine L Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1328-34. PubMed ID: 20506493 [TBL] [Abstract][Full Text] [Related]
38. Dengue infection triggered immune mediated necrotizing myopathy in children: a case report and literature review. Mekmangkonthong A; Amornvit J; Numkarunarunrote N; Veeravigrom M; Khaosut P Pediatr Rheumatol Online J; 2022 Jun; 20(1):40. PubMed ID: 35672822 [TBL] [Abstract][Full Text] [Related]